BSI SA provides asset management and related services to private and institutional clients in Switzerland and internationally.
BSI SA provides asset management and related services to private and institutional clients in Switzerland and internationally. The company offers services relating to asset management, including investment funds; placing of fiduciary deposits; and trading in currencies and securities, precious metals, and foreign exchange. Its services include corporate finance services, such as services for mergers and acquisitions, capital markets, and business evaluations; and life insurance solutions as an agent. The company also offers financial planning, advisory, and credit services. As of December 31, 2008, it operated through a network of seven branches in Switzerland; seven representative offices in Athens, Buenos Aires, Hong Kong, Montevideo, Panama, Taipei, and Bahrain; and six banks in Bahamas, Luxembourg, Madrid, Monte Carlo, Paris, and Singapore. The company was founded in 1873 and is headquartered in Lugano, Switzerland. BSI SA operates as a subsidiary of Participatie Maatschappij Graafschap Holland N.V.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 10, 2011
VisionCare Ophthalmic Technologies
|
Series E | $31M | Health Care | — |
Jan 19, 2010
GlobeImmune
|
Series E | $17.50M | Biotechnology | — |
Sep 30, 2008
Telormedix
|
Series A | $19M | Biopharma | — |
Jan 6, 2006
Perlegen Sciences
|
Series D | $50M | Biotechnology | — |
Feb 28, 2005
Perlegen Sciences
|
Series D | $74M | Biotechnology | — |
BSI SA has had 2 exits. BSI SA most notable exits include GlobeImmune , Telormedix
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jul 5, 2016 | GlobeImmune | IPO | Biotechnology | Detail |
Jan 1, 2015 | Telormedix | M&A | Biopharma | Detail |